In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy

Clinical applications

Angelo Del Sole, Anna Gambini, Andrea Falini, Michela Lecchi, Giovanni Lucignani

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The assessment of neurochemical processes in vivo has received much attention in the past decade as techniques such as positron or single photon emission tomography (PET and SPET), and magnetic resonance spectroscopy (MRS) have become more available. With PET and SPET, basic processes, such as blood flow and oxygen or glucose metabolism, can be regionally assessed, along with more specific functions such as the production, release, and reuptake of neurotransmitters and their occupancy of specific receptors. At the same time, MRS can reveal changes in concentration of several hydrogenate compounds in the brain. All these methods have been extensively applied for research in neurology, and some applications have reached the clinical level, namely for the study of degenerative diseases, motor-neuron diseases, movement disorders, cerebrovascular diseases, and epilepsy. This article focuses on the most relevant information that can be obtained with these complementary techniques to help clinicians in the assessment of neurological diseases.

Original languageEnglish
Pages (from-to)2582-2599
Number of pages18
JournalEuropean Radiology
Volume12
Issue number10
Publication statusPublished - Oct 1 2002

Fingerprint

Neurochemistry
Magnetic Resonance Spectroscopy
Tomography
Cerebrovascular Disorders
Motor Neuron Disease
Process Assessment (Health Care)
Movement Disorders
Neurology
Photons
Neurotransmitter Agents
Epilepsy
Electrons
Oxygen
Glucose
Brain
Research

Keywords

  • Alzheimer's disease
  • Epilepsy
  • MR spectroscopy
  • Neuroimaging
  • Neurotransmitters
  • Parkinson's disease
  • Positron emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy : Clinical applications. / Del Sole, Angelo; Gambini, Anna; Falini, Andrea; Lecchi, Michela; Lucignani, Giovanni.

In: European Radiology, Vol. 12, No. 10, 01.10.2002, p. 2582-2599.

Research output: Contribution to journalArticle

Del Sole, A, Gambini, A, Falini, A, Lecchi, M & Lucignani, G 2002, 'In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy: Clinical applications', European Radiology, vol. 12, no. 10, pp. 2582-2599.
Del Sole, Angelo ; Gambini, Anna ; Falini, Andrea ; Lecchi, Michela ; Lucignani, Giovanni. / In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy : Clinical applications. In: European Radiology. 2002 ; Vol. 12, No. 10. pp. 2582-2599.
@article{d79268fcd6fd4325a525b452405a4515,
title = "In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy: Clinical applications",
abstract = "The assessment of neurochemical processes in vivo has received much attention in the past decade as techniques such as positron or single photon emission tomography (PET and SPET), and magnetic resonance spectroscopy (MRS) have become more available. With PET and SPET, basic processes, such as blood flow and oxygen or glucose metabolism, can be regionally assessed, along with more specific functions such as the production, release, and reuptake of neurotransmitters and their occupancy of specific receptors. At the same time, MRS can reveal changes in concentration of several hydrogenate compounds in the brain. All these methods have been extensively applied for research in neurology, and some applications have reached the clinical level, namely for the study of degenerative diseases, motor-neuron diseases, movement disorders, cerebrovascular diseases, and epilepsy. This article focuses on the most relevant information that can be obtained with these complementary techniques to help clinicians in the assessment of neurological diseases.",
keywords = "Alzheimer's disease, Epilepsy, MR spectroscopy, Neuroimaging, Neurotransmitters, Parkinson's disease, Positron emission tomography",
author = "{Del Sole}, Angelo and Anna Gambini and Andrea Falini and Michela Lecchi and Giovanni Lucignani",
year = "2002",
month = "10",
day = "1",
language = "English",
volume = "12",
pages = "2582--2599",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy

T2 - Clinical applications

AU - Del Sole, Angelo

AU - Gambini, Anna

AU - Falini, Andrea

AU - Lecchi, Michela

AU - Lucignani, Giovanni

PY - 2002/10/1

Y1 - 2002/10/1

N2 - The assessment of neurochemical processes in vivo has received much attention in the past decade as techniques such as positron or single photon emission tomography (PET and SPET), and magnetic resonance spectroscopy (MRS) have become more available. With PET and SPET, basic processes, such as blood flow and oxygen or glucose metabolism, can be regionally assessed, along with more specific functions such as the production, release, and reuptake of neurotransmitters and their occupancy of specific receptors. At the same time, MRS can reveal changes in concentration of several hydrogenate compounds in the brain. All these methods have been extensively applied for research in neurology, and some applications have reached the clinical level, namely for the study of degenerative diseases, motor-neuron diseases, movement disorders, cerebrovascular diseases, and epilepsy. This article focuses on the most relevant information that can be obtained with these complementary techniques to help clinicians in the assessment of neurological diseases.

AB - The assessment of neurochemical processes in vivo has received much attention in the past decade as techniques such as positron or single photon emission tomography (PET and SPET), and magnetic resonance spectroscopy (MRS) have become more available. With PET and SPET, basic processes, such as blood flow and oxygen or glucose metabolism, can be regionally assessed, along with more specific functions such as the production, release, and reuptake of neurotransmitters and their occupancy of specific receptors. At the same time, MRS can reveal changes in concentration of several hydrogenate compounds in the brain. All these methods have been extensively applied for research in neurology, and some applications have reached the clinical level, namely for the study of degenerative diseases, motor-neuron diseases, movement disorders, cerebrovascular diseases, and epilepsy. This article focuses on the most relevant information that can be obtained with these complementary techniques to help clinicians in the assessment of neurological diseases.

KW - Alzheimer's disease

KW - Epilepsy

KW - MR spectroscopy

KW - Neuroimaging

KW - Neurotransmitters

KW - Parkinson's disease

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=0036781030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036781030&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 2582

EP - 2599

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 10

ER -